Stockreport

CNL’S CNRI-H Program Continues Strong Growth Thanks to New Projects With Repare Therapeutics and Defence Therapeutics [Canadian Business Journal (Canada)]

Repare Therapeutics Inc. - Common Shares  (RPTX) 
PDF Canada’s national nuclear laboratories announces new projects with leading Canadian biopharmaceutical companies through collaborative research programCHALK RIVER, Ontari [Read more]